We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

February 22, 2011

Vivelle Ventures LLC et al v. Mylan Technologies, Inc. et al

Track this case

Case Number:

1:11-cv-01187

Court:

New York Southern

Nature of Suit:

Patent

Judge:

Katherine B. Forrest

Firms

Companies

Sectors & Industries:

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. November 21, 2011

    Novartis, Mylan Settle Feud Over Generic Vivelle-Dot

    Drugmakers Novartis AG and Mylan Inc. have settled patent litigation over Mylan's bid to produce a generic version of Novartis' estrogen therapy drug Vivelle-Dot, which will allow the generic to be manufactured, Mylan announced Monday.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS